Hyperliquid vs Mitosis — how do they compare? Hyperliquid trades at Rp1,026,579 (market cap Rp259,9T, Rp5,07T 24h volume), while Mitosis trades at Rp448.91 (market cap Rp81,64M, Rp75,67M 24h volume). The key difference: Hyperliquid is far larger — about 3183488.5× Mitosis's market cap, and Hyperliquid's circulating supply is 252,6M / 952,7M HYPE (27%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Hyperliquid for 36 Days and Mitosis for 20 Days on average.
| HYPE | MITO | |
|---|---|---|
Market Cap | Rp259,9T | Rp81,64M |
Volume (24h) | Rp5,07T | Rp75,67M |
Circulating Supply | 252,6M / 952,7M HYPE (27%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 36 Days | 20 Days |
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hyperliquid is an advanced blockchain platform designed to improve the efficiency and performance of decentralized finance (DeFi) applications. It is built on a custom Layer 1 blockchain that has been specifically engineered for optimal scalability and speed. A key feature of its design is HyperBFT, a proprietary consensus mechanism that provides rapid transaction finality while ensuring high security standards.
Read more on HYPE →Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →